| Polygenic susceptibility to breast cancer and implications for prevention PDP Pharoah, A Antoniou, M Bobrow, RL Zimmern, DF Easton, ... Nature genetics 31 (1), 33-36, 2002 | 1014 | 2002 |
| Genetic causes of monogenic heterozygous familial hypercholesterolemia: a HuGE prevalence review MA Austin, CM Hutter, RL Zimmern, SE Humphries American journal of epidemiology 160 (5), 407-420, 2004 | 836 | 2004 |
| Familial hypercholesterolemia and coronary heart disease: a HuGE association review MA Austin, CM Hutter, RL Zimmern, SE Humphries American journal of epidemiology 160 (5), 421-429, 2004 | 508 | 2004 |
| Recommendations for returning genomic incidental findings? We need to talk! W Burke, AH Matheny Antommaria, R Bennett, J Botkin, EW Clayton, ... Genetics in Medicine 15 (11), 854-859, 2013 | 337 | 2013 |
| A road map for efficient and reliable human genome epidemiology JPA Ioannidis, M Gwinn, J Little, JPT Higgins, JL Bernstein, P Boffetta, ... Nature Genetics 38 (1), 3-5, 2006 | 269 | 2006 |
| Predicting the likelihood of carrying a BRCA1 or BRCA2 mutation: validation of BOADICEA, BRCAPRO, IBIS, Myriad and the Manchester scoring system using data from UK genetics clinics AC Antoniou, R Hardy, L Walker, DG Evans, A Shenton, R Eeles, ... Journal of medical genetics 45 (7), 425-431, 2008 | 229 | 2008 |
| The path from genome-based research to population health: development of an international public health genomics network W Burke, MJ Khoury, A Stewart, RL Zimmern Genetics in Medicine 8 (7), 451-458, 2006 | 201 | 2006 |
| Next-generation sequencing in the clinic: are we ready? LG Biesecker, W Burke, I Kohane, SE Plon, R Zimmern Nature Reviews Genetics 13 (11), 818-824, 2012 | 166 | 2012 |
| A collaboratively-derived science-policy research agenda WJ Sutherland, L Bellingan, JR Bellingham, JJ Blackstock, RM Bloomfield, ... PloS one 7 (3), e31824, 2012 | 166 | 2012 |
| Subtle disturbances of vision after optic neuritis elicited by studying contrast sensitivity. RL Zimmern, FW Campbell, IM Wilkinson Journal of Neurology, Neurosurgery & Psychiatry 42 (5), 407-412, 1979 | 131 | 1979 |
| How can the evaluation of genetic tests be enhanced? Lessons learned from the ACCE framework and evaluating genetic tests in the United Kingdom S Sanderson, R Zimmern, M Kroese, J Higgins, C Patch, J Emery Genetics in Medicine 7 (7), 495-500, 2005 | 130 | 2005 |
| Differences in the neural basis of human amblyopias: the effect of mean luminance RF Hess, FW Campbell, R Zimmern Vision research 20 (4), 295-305, 1980 | 117 | 1980 |
| Extending the reach of public health genomics: what should be the agenda for public health in an era of genome-based and “personalized” medicine? W Burke, H Burton, AE Hall, M Karmali, MJ Khoury, B Knoppers, ... Genetics in Medicine 12 (12), 785-791, 2010 | 110 | 2010 |
| Transient visually evoked potentials to the pattern reversal and onset of sinusoidal gratings. GT Plant, RL Zimmern, K Durden Electroencephalography and Clinical Neurophysiology 56 (2), 147-158, 1983 | 110 | 1983 |
| Genetic testing and common disorders in a public health framework: how to assess relevance and possibilities F Becker, CG Van El, D Ibarreta, E Zika, S Hogarth, P Borry, ... European journal of human genetics 19 (1), S6-S44, 2011 | 109 | 2011 |
| The emergence of networks in human genome epidemiology: challenges and opportunities D Seminara, MJ Khoury, TR O'brien, T Manolio, ML Gwinn, J Little, ... Epidemiology 18 (1), 1-8, 2007 | 88 | 2007 |
| Will genomics widen or help heal the schism between medicine and public health? MJ Khoury, M Gwinn, W Burke, S Bowen, R Zimmern American journal of preventive medicine 33 (4), 310-317, 2007 | 84 | 2007 |
| The evaluation of genetic tests RL Zimmern, M Kroese Journal of Public Health 29 (3), 246-250, 2007 | 74 | 2007 |
| Genetic tests for common diseases: new insights, old concerns D Melzer, S Hogarth, K Liddell, T Ling, S Sanderson, RL Zimmern Bmj 336 (7644), 590-593, 2008 | 72 | 2008 |
| Genetics and medicalisation: genetics could drive a new wave of medicalisation if genetic tests are accepted without appropriate clinical evaluation D Melzer, R Zimmern Bmj 324 (7342), 863-864, 2002 | 69 | 2002 |
